Bispecific Antibodies in Lung Cancer: A State-of-the-Art Review

Bispecific antibodies have emerged as a promising class of therapeutics in the field of oncology, offering an innovative approach to target cancer cells while sparing healthy tissues. These antibodies are designed to bind two different antigens, enabling them to bridge immune cells with cancer cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Khosla, Atulya Aman, Jatwani, Karan, Singh, Rohit, Reddy, Aswanth, Jaiyesimi, Ishmael, Desai, Aakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609957/
https://www.ncbi.nlm.nih.gov/pubmed/37895932
http://dx.doi.org/10.3390/ph16101461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609957/
https://www.ncbi.nlm.nih.gov/pubmed/37895932
http://dx.doi.org/10.3390/ph16101461

Ejemplares similares